i took too much semaglutide Overdose Risks: What GLP-1 Does Retatrutide for weight loss: Study

Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class

and VANDERAH, T

Reusing Needles MT-2 protocols involve frequent injections over weeks

Bethany Berrios, DNP Chief Nursing Officer Melissa Hoperich, APRN Chief Nursing Officer Functional Medicine & Weight Management Dr

Overgaard RV, Lindberg S, Thielke D

Peretti A, FitzGerald PC, Bliskovsky V, Buck CB, Pastrana DV